Clinical Trial Update: Etoricoxib in Patients With Parkinsonian Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for etoricoxib in Parkinson disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Etoricoxib (etoricoxib)

Snippet

Sponsor: Ihab Elsayed Hassan | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING